|
1
|
Orditura M, Galizia G, Sforza V,
Gambardella V, Fabozzi A, Laterza MM, Andreozzi F, Ventriglia J,
Savastano B, Mabilia A, et al: Treatment of gastric cancer. World J
Gastroenterol. 20:1635–1649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sun J, Song Y, Wang Z, Chen X, Gao P, Xu
Y, Zhou B and Xu H: Clinical significance of palliative gastrectomy
on the survival of patients with incurable advanced gastric cancer:
A systematic review and meta-analysis. BMC Cancer. 13:5772013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kang JA, Yang Z, Lee JY, De U, Kim TH,
Park JY, Lee HJ, Park YJ, Chun P, Kim HS, et al: Design, synthesis
and anticancer activity of novel
dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivatives. Bioorg
Med Chem Lett. 21:5730–5734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee SH, Kang YJ, Sung B, Kim DH, Lim HS,
Kim HR, Kim SJ, Yoon JH, Moon HR, Chung HY, et al: MHY-449, a novel
dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces
apoptotic cell death through modulation of Akt/FoxO1 and ERK
signaling in PC3 human prostate cancer cells. Int J Oncol.
44:905–911. 2014.PubMed/NCBI
|
|
5
|
Hwang HJ, Kang YJ, Hossain MA, Kim DH,
Jang JY, Lee SH, Yoon JH, Moon HR, Kim HS, Chung HY, et al: Novel
dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivative, MHY-449,
induces apoptosis and cell cycle arrest in HCT116 human colon
cancer cells. Int J Oncol. 41:2057–2064. 2012.PubMed/NCBI
|
|
6
|
Hiromura K, Pippin JW, Fero ML, Roberts JM
and Shankland SJ: Modulation of apoptosis by the cyclin-dependent
kinase inhibitor p27(Kip1). J Clin Invest. 103:597–604. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kaufmann SH, Lee SH, Meng XW, Loegering
DA, Kottke TJ, Henzing AJ, Ruchaud S, Samejima K and Earnshaw WC:
Apoptosis-associated caspase activation assays. Methods.
44:262–272. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang J and Yi J: Cancer cell killing via
ROS: To increase or decrease, that is the question. Cancer Biol
Ther. 7:1875–1884. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu WS: The signaling mechanism of ROS in
tumor progression. Cancer Metastasis Rev. 25:695–705. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Watson J: Oxidants, antioxidants and the
current incurability of metastatic cancers. Open Biol.
3:1201442013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
David-Cordonnier MH, Laine W, Lansiaux A,
Kouach M, Briand G, Pierré A, Hickman JA and Bailly C: Alkylation
of guanine in DNA by S23906-1, a novel potent antitumor compound
derived from the plant alkaloid acronycine. Biochemistry.
41:9911–9920. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thi Mai HD, Gaslonde T, Michel S,
Tillequin F, Koch M, Bongui JB, Elomri A, Seguin E, Pfeiffer B,
Renard P, et al: Structure-activity relationships and mechanism of
action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine
analogues. J Med Chem. 46:3072–3082. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guilbaud N, Kraus-Berthier L, Meyer-Losic
F, Malivet V, Chacun C, Jan M, Tillequin F, Michel S, Koch M,
Pfeiffer B, et al: Marked antitumor activity of a new potent
acronycine derivative in orthotopic models of human solid tumors.
Clin Cancer Res. 7:2573–2580. 2001.PubMed/NCBI
|
|
14
|
Léonce S, Pérez V, Lambel S, Peyroulan D,
Tillequin F, Michel S, Koch M, Pfeiffer B, Atassi G, Hickman JA, et
al: Induction of cyclin E and inhibition of DNA synthesis by the
novel acronycine derivative S23906-1 precede the irreversible
arrest of tumor cells in S phase leading to apoptosis. Mol
Pharmacol. 60:1383–1391. 2001.PubMed/NCBI
|
|
15
|
Kluza J, Lansiaux A, Wattez N, Hildebrand
MP, Léonce S, Pierré A, Hickman JA and Bailly C: Induction of
apoptosis in HL-60 leukemia and B16 melanoma cells by the
acronycine derivative S23906-1. Biochem Pharmacol. 63:1443–1452.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suen DF, Norris KL and Youle RJ:
Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Waring P and Mullbacher A: Cell death
induced by the Fas/Fas ligand pathway and its role in pathology.
Immunol Cell Biol. 77:312–317. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vogelstein B, Lane D and Levine AJ:
Surfing the p53 network. Nature. 408:307–310. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abbas T and Dutta A: p21 in cancer:
Intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Craig C, Wersto R, Kim M, Ohri E, Li Z,
Katayose D, Lee SJ, Trepel J, Cowan K and Seth P: A recombinant
adenovirus expressing p27Kip1 induces cell cycle arrest and loss of
cyclin-Cdk activity in human breast cancer cells. Oncogene.
14:2283–2289. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tait SW and Green DR: Caspase-independent
cell death: Leaving the set without the final cut. Oncogene.
27:6452–6461. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kolenko VM, Uzzo RG, Bukowski R and Finke
JH: Caspase-dependent and -independent death pathways in cancer
therapy. Apoptosis. 5:17–20. 2000. View Article : Google Scholar
|
|
23
|
Fang J, Nakamura H and Iyer AK:
Tumor-targeted induction of oxystress for cancer therapy. J Drug
Target. 15:475–486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zamzami N, Marchetti P, Castedo M,
Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B and
Kroemer G: Sequential reduction of mitochondrial transmembrane
potential and generation of reactive oxygen species in early
programmed cell death. J Exp Med. 182:367–377. 1995. View Article : Google Scholar : PubMed/NCBI
|
